LFSC Holdings — F/m Emerald Life Sciences Innovation ETF
All 40 reported holdings of F/m Emerald Life Sciences Innovation ETF (LFSC) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Travere Therapeutics Inc | 7.67% | $8.05M |
| Cogent Biosciences Inc | 7.53% | $7.91M |
| LivaNova PLC | 7.11% | $7.47M |
| Spyre Therapeutics Inc | 6.41% | $6.73M |
| Guardant Health Inc | 5.52% | $5.80M |
| Mirum Pharmaceuticals Inc | 4.92% | $5.17M |
| Corcept Therapeutics Inc | 4.79% | $5.03M |
| United Therapeutics Corp | 4.16% | $4.37M |
| VeraDermics Inc | 3.42% | $3.59M |
| Savara Inc | 3.22% | $3.39M |
| Cytokinetics Inc | 3.16% | $3.32M |
| Nektar Therapeutics | 3.14% | $3.30M |
| Trevi Therapeutics Inc | 3.12% | $3.27M |
| Dianthus Therapeutics Inc | 3.09% | $3.24M |
| Axsome Therapeutics Inc | 2.84% | $2.98M |
| Billiontoone Inc | 2.73% | $2.87M |
| TransMedics Group Inc | 2.68% | $2.82M |
| Viridian Therapeutics Inc | 2.23% | $2.35M |
| ICU Medical Inc | 2.09% | $2.20M |
| Corvus Pharmaceuticals Inc | 1.95% | $2.05M |
| Palvella Therapeutics Inc | 1.95% | $2.04M |
| Ceribell Inc | 1.55% | $1.63M |
| Globus Medical Inc | 1.27% | $1.33M |
| Xeris Biopharma Holdings Inc | 1.22% | $1.28M |
| Bridgebio Pharma Inc | 1.17% | $1.23M |
| Integer Holdings Corp | 1.14% | $1.20M |
| Twist Bioscience Corp | 1.14% | $1.19M |
| F/m Ultrashort Treasury Inflat | 1.08% | $1.14M |
| Waystar Holding Corp | 1.05% | $1.10M |
| WaVe Life Sciences Ltd | 0.95% | $1.00M |
| Hinge Health Inc | 0.94% | $988.73K |
| Korro Bio Inc | 0.80% | $842.89K |
| RadNet Inc | 0.79% | $827.34K |
| Aveanna Healthcare Holdings In | 0.72% | $758.44K |
| Lumexa Imaging Holdings Inc | 0.70% | $738.92K |
| Insmed Inc | 0.62% | $646.81K |
| Alphatec Holdings Inc | 0.57% | $599.74K |
| NeoGenomics Inc | 0.43% | $453.11K |
| Alamar Biosciences Inc | 0.18% | $192.99K |
| U.S. Bank Money Market Deposit Account | 0.00% | $203 |
LFSC overview: performance, fees, allocation and SEC filings